Is Alkem Laboratories stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Alkem Laboratories pays dividends. Last time was Sunday 29th of September 2024 where the investors holding the stock on Thursday 8th of August 2024 were paid INR5 per share. Over the last 17 times between 2016 and 2024, Alkem Laboratories has paid INR217.7 with an average of INR12.81 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Alkem Laboratories 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR1 800.00, you would have made a profit of INR4 509.95 per share or 250.55%
Yes, the average daily trading liquidity for Alkem Laboratories is INR273 661 thousand. You should therefore be able to get in and out of your positions relatively fast.
Alkem Laboratories has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.48, the company's ability to pay off the debt is normal. Alkem Laboratories has a good net profit margin of 14.18% and should have high tolerances against inflation.
We have calculated the inflation risk for Alkem Laboratories to be low [0.25 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.